Low Incidence and Brief Duration of Gastrointestinal Adverse Events with Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Over 96 Weeks: Post hoc Analyses of AMBER and EMERALD
Dunn, Keith, Baugh, Bryan, Bejou, Nika, Luo, Donghan, Campbell, Jennifer, Seyedkazemi, Sareh, Anderson, David
Published in Journal of the International Association of Providers of AIDS Care (01.01.2022)
Published in Journal of the International Association of Providers of AIDS Care (01.01.2022)
Get full text
Journal Article
Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients
Zeuzem, Stefan, DeMasi, Ralph, Baldini, Alessandra, Coate, Bruce, Luo, Donghan, Mrus, Joseph, Witek, James
Published in Journal of hepatology (01.06.2014)
Published in Journal of hepatology (01.06.2014)
Get full text
Journal Article
Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial
Benhamou, Yves, Moussalli, Joseph, Ratziu, Vlad, Lebray, Pascal, De Backer, Katrien, De Meyer, Sandra, Ghys, Anne, Luo, Donghan, Picchio, Gaston R., Beumont, Maria
Published in The Journal of infectious diseases (15.09.2013)
Published in The Journal of infectious diseases (15.09.2013)
Get full text
Journal Article
Rapid initiation of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in acute and early HIV-1 infection: a DIAMOND subgroup analysis
Dunn, Keith, Rogers, Rachel, Simonson, Richard Bruce, Luo, Donghan, Sheng, Shubin, Kassam, Purnima T, Seyedkazemi, Sareh, Hardy, Hélène
Published in HIV research & clinical practice (13.07.2021)
Published in HIV research & clinical practice (13.07.2021)
Get full text
Journal Article
Pooled resistance analyses of darunavir once-daily regimens and formulations across 10 clinical studies of treatment-naïve and treatment-experienced patients with human immunodeficiency virus-1 infection
Erkki Lathouwers, Sareh Seyedkazemi, Donghan Luo, Kimberley Brown, Sandra De Meyer, Eric Y. Wong
Published in HIV research & clinical practice (25.07.2020)
Published in HIV research & clinical practice (25.07.2020)
Get full text
Journal Article
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study
Huhn, Gregory D, Eron, Joseph J, Girard, Pierre-Marie, Orkin, Chloe, Molina, Jean-Michel, DeJesus, Edwin, Petrovic, Romana, Luo, Donghan, Van Landuyt, Erika, Lathouwers, Erkki, Nettles, Richard E, Brown, Kimberley, Wong, Eric Y
Published in AIDS research and therapy (29.08.2019)
Published in AIDS research and therapy (29.08.2019)
Get full text
Journal Article
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study
Lawitz, Eric, Poordad, Fred, Gutierrez, Julio A., Beumont, Maria, Beets, Greet, Vandevoorde, Ann, Remoortere, Pieter Van, Luo, Donghan, Vijgen, Leen, Eygen, Veerle Van, Gamil, Mohamed
Published in Health science reports (01.06.2020)
Published in Health science reports (01.06.2020)
Get full text
Journal Article
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naïve patients with HIV-1: subgroup analyses of the phase 3 AMBER study
Rashbaum, Bruce, Spinner, Christoph D, McDonald, Cheryl, Mussini, Cristina, Jezorwski, John, Luo, Donghan, Van Landuyt, Erika, Brown, Kimberley, Wong, Eric Y
Published in HIV research & clinical practice (02.01.2019)
Published in HIV research & clinical practice (02.01.2019)
Get full text
Journal Article
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment‐naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis
Dunn, Keith, Bushen, Jennifer, Luo, Donghan, Cai, Jiyun, Simonson, Richard Bruce, Anderson, David
Published in HIV medicine (01.03.2023)
Published in HIV medicine (01.03.2023)
Get full text
Journal Article
Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study
Huhn, Gregory D, Crofoot, Gordon, Ramgopal, Moti, Gathe, Joseph, Bolan, Robert, Luo, Donghan, Simonson, Richard Bruce, Nettles, Richard E, Benson, Carmela, Dunn, Keith
Published in Clinical infectious diseases (15.12.2020)
Published in Clinical infectious diseases (15.12.2020)
Get full text
Journal Article
Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C
Marcellin, Patrick, Forns, Xavier, Goeser, Tobias, Ferenci, Peter, Nevens, Frederik, Carosi, Giampiero, Drenth, Joost P, Serfaty, Lawrence, De Backer, Koen, Van Heeswijk, Rolf, Luo, Donghan, Picchio, Gaston, Beumont, Maria
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2011)
Published in Gastroenterology (New York, N.Y. 1943) (01.02.2011)
Get full text
Journal Article
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial
Mambule, Ivan K, Mugerwa, Henry, Ategeka, Gilbert, Siika, Abraham, Kosgei, Josphat, Shah, Reena, Naidoo, Logashvari, Opiyo, Kimton, Otike, Caroline, Kaimal, Arvind, Wambui, Charity, Addo Boateng, Fafa, Paton, Nicholas I, Mugerwa, Henry, Tamale, William, Asaasira, Susan Esther, Kinyera, Nigel, Nakiboneka, Dridah Luyirika, Kabatana, Rose, Kiyimba, Winfred, Ategeka, Gilbert, Yawe, Ibrahim, Zawedde, Aidah, Wasswa, George, Arinda, Allan, Rweyora, Angela, Kangah, Mary Goretti, Cresswell, Fiona, Kaimal, Arvind, Muhumuza, Neville, Okwero, Max, Ayebare, Peruth, Asienzo, Jesca, Shah, Reena, Riunga, Felix, Onyango, Peter Odhiambo, Sayed, Shaheen, Gohil, Jaimini, Mungathia, Isaiah, Githuka, Alfred Mburu, Kibwage, Haron, Wambui, Charity Kanyoro, Kirui, Viola Cherotich, Kipyego, Jairus, Sang, Natalie, Mboya, Chris Sande, Tonui, Ronald, Njulu, Florence, Kosgei, Josphat, Sawe, Fredrick, Omol, Magdaline Adhiambo, Riziki, Faith, Daud, Ibrahim, Kimetto, Leelgo, Okumu, Billy Omalla, Lipuku, Francis, Sokhela, Simiso, Venter, Francois, Moller, Karlien, Nzuza, Nompumelelo, Ramela, Gontse, Tom, Noxolo, Macholo, Philadelphia, Macebele, Hlamulani, Akpomiemie, Godspower, Naidoo, Logashvari, Jeenarain, Nitesha, Reddy, Mayuri, Kityo, Cissy, Paton, Nicholas, Mambule, Ivan Kiggundu, Opiyo, Kimton, Musaazi, Joseph, Otike, Caroline, Kabanyoro, Ritah, Sekajja, Francis, Nantumbwe, Sandra, Ouma, Benson, Lötter, Melissa, Mohamed, Saeeda, Herbst, Madel, Mehta, Heena, Kruger, Marlien, van Rein-van der Horst, Willemijn, Addo Boateng, Fafa, Van Solingen, Rodica, Van Eygen, Veerle, Luo, Donghan, Votto, Donna, Idahosa, Awhonukeh, Mwendia, Fridah, Bondal, Malavika, Eshun-Wilsonova, Ingrid, Mohammed, Perry, D'Amico, Ronald, Kaleebu, Pontiano, Ojoo, Sylvia, Katana, Milly, Moosa, Yunus, Munderi, Paula
Published in The Lancet infectious diseases (28.05.2024)
Published in The Lancet infectious diseases (28.05.2024)
Get full text
Journal Article
Sa1516 - Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection with or without Cirrhosis Treated with Interferon-Free, Simeprevir-Containing Regimens: Results from Four Phase II/III Studies
Chan, Eric, Lawitz, Eric, Kwo, Paul Yien, Sulkowski, Mark S., Gamil, Mohamed, Corbett, Chris, Luo, Donghan, Scott, Jane A.
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen
Bourgeois, Stefan, Horsmans, Yves, Nevens, Frederik, van Vlierberghe, Hans, Moreno, Christophe, Beumont, Maria, Vijgen, Leen, van Eygen, Veerle, Luo, Donghan, Hillewaert, Vera, Van Remoortere, Pieter, van de Logt, Jolanda, Ouwerkerk-Mahadevan, Sivi
Published in Antimicrobial agents and chemotherapy (01.12.2017)
Published in Antimicrobial agents and chemotherapy (01.12.2017)
Get full text
Journal Article
1015. Gastrointestinal (GI) Adverse Events With Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Through Week 96: An AMBER Post Hoc Analysis
Dunn, Keith, Huang, Yangxin, Baugh, Bryan, Bejou, Nika, Luo, Donghan, Campbell, Jennifer, Anderson, David
Published in Open forum infectious diseases (31.12.2020)
Published in Open forum infectious diseases (31.12.2020)
Get full text
Journal Article
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay
Sarrazin, Christoph, Dierynck, Inge, Cloherty, Gavin, Ghys, Anne, Janssen, Katrien, Luo, Donghan, Witek, James, Buti, Maria, Picchio, Gaston, De Meyer, Sandra
Published in Journal of clinical microbiology (01.04.2015)
Published in Journal of clinical microbiology (01.04.2015)
Get full text
Journal Article
Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection with or without Cirrhosis Treated with Interferon-Free, Simeprevir-Containing Regimens: Results from Four Phase II/III Studies
Chan, Eric, Lawitz, Eric, Kwo, Paul Yien, Sulkowski, Mark S, Gamil, Mohamed, Corbett, Chris, Luo, Donghan, Scott, Jane A
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Published in Gastroenterology (New York, N.Y. 1943) (01.04.2017)
Get full text
Journal Article
Telaprevir Twice Daily Is Noninferior to Telaprevir Every 8 Hours for Patients With Chronic Hepatitis C
Buti, Maria, Agarwal, Kosh, Horsmans, Yves, Sievert, William, Janczewska, Ewa, Zeuzem, Stefan, Nyberg, Lisa, Brown, Robert S, Hézode, Christophe, Rizzetto, Mario, Paraná, Raymundo, De Meyer, Sandra, De Masi, Ralph, Luo, Donghan, Bertelsen, Kirk, Witek, James
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2014)
Published in Gastroenterology (New York, N.Y. 1943) (01.03.2014)
Get full text
Journal Article
2509. Pooled Resistance Analyses of Darunavir (DRV) Once Daily (QD) Regimens and Formulations Across 10 Clinical Studies of Treatment-Naïve (TN) and Treatment-Experienced (TE) Patients with Human Immunodeficiency Virus (HIV)-1 Infection
Lathouwers, Erkki, Seyedkazemi, Sareh, Luo, Donghan, Brown, Kimberley, De Meyer, Sandra, Wong, Eric Y
Published in Open forum infectious diseases (23.10.2019)
Published in Open forum infectious diseases (23.10.2019)
Get full text
Journal Article
Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir
Opsomer, Magda, Dimitrova, Dessislava, Verspeelt, Johan, Purrington, Amy, Mehbob, Abdul, Chavers, Scott, Pai, Helen, Vanveggel, Simon, Luo, Donghan, Brown, Kimberley, Moecklinghoff, Christiane, Nettles, Richard E., Boven, Katia
Published in Drugs in R&D (01.09.2018)
Published in Drugs in R&D (01.09.2018)
Get full text
Journal Article